Emmessar Biotech & Nutrition Ltd

AI

Emmessar Biotech & Nutrition Ltd

₹ 23.3 -2.92%
22 Sep - close price
About

Emmessar Biotech & Nutrition Ltd is a standalone healthcare-products and property-leasing company. It manufactures /trades a small VedaCeuticals portfolio and earns rent from sub-leasing its MIDC Taloja industrial land; FY26 filings report Healthcare and Rent on Leasehold Land as the only operating segments.[1]

Key Points

Business Overview:[1]
EBNL is a global healthcare company
that manufactures and markets health
care & nutritional products. It fuses
various concepts & principles (both
ancient & modern) from Biophysics, Biochemistry, Biotechnology and
the Indian system of medicine AYUSH
(Ayurveda + Yoga + Unani + Siddha
+ Homeopathy) to create products.
This integration resulted in technology
called VedaCeuticals which forms
the foundation of all products of
EBNL

  • Market Cap 11.6 Cr.
  • Current Price 23.3
  • High / Low 36.2 / 18.4
  • Stock P/E 29.8
  • Book Value 16.2
  • Dividend Yield 0.00 %
  • ROCE 7.33 %
  • ROE 5.56 %
  • Face Value 10.0

Pros

  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -44.4% over past five years.
  • Company has a low return on equity of 6.71% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
0.07 0.08 0.33 0.08 0.08 0.34 0.10 0.10 0.09 0.09 0.09 0.09 0.06
0.35 0.30 0.54 0.47 0.36 0.42 0.38 0.43 0.36 0.46 0.43 0.46 0.41
Operating Profit -0.28 -0.22 -0.21 -0.39 -0.28 -0.08 -0.28 -0.33 -0.27 -0.37 -0.34 -0.37 -0.35
OPM % -400.00% -275.00% -63.64% -487.50% -350.00% -23.53% -280.00% -330.00% -300.00% -411.11% -377.78% -411.11% -583.33%
0.46 0.53 0.53 0.48 0.46 0.51 0.43 0.61 0.53 0.54 0.49 0.47 0.54
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.02
Profit before tax 0.16 0.29 0.30 0.07 0.16 0.41 0.13 0.26 0.24 0.14 0.12 0.07 0.17
Tax % 68.75% 31.03% 56.67% -285.71% 43.75% 31.71% 84.62% 126.92% 25.00% 21.43% 8.33% 57.14% 17.65%
0.05 0.20 0.13 0.27 0.09 0.28 0.02 -0.07 0.17 0.11 0.12 0.03 0.13
EPS in Rs 0.10 0.40 0.26 0.54 0.18 0.56 0.04 -0.14 0.34 0.22 0.24 0.06 0.26
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
2.19 1.98 2.61 1.27 0.63 3.40 6.99 0.36 1.02 0.56 0.61 0.37 0.33
2.34 2.66 2.38 1.67 1.27 3.81 6.15 1.26 1.71 1.64 1.56 1.73 1.76
Operating Profit -0.15 -0.68 0.23 -0.40 -0.64 -0.41 0.84 -0.90 -0.69 -1.08 -0.95 -1.36 -1.43
OPM % -6.85% -34.34% 8.81% -31.50% -101.59% -12.06% 12.02% -250.00% -67.65% -192.86% -155.74% -367.57% -433.33%
0.06 0.03 0.98 1.25 1.01 1.21 1.47 1.92 1.75 1.99 2.01 2.04 2.04
Interest 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.07 0.03 0.01 0.05 0.08 0.06 0.06 0.09 0.09 0.10 0.10 0.10 0.11
Profit before tax -0.16 -0.68 1.19 0.80 0.29 0.74 2.25 0.93 0.97 0.81 0.96 0.58 0.50
Tax % -25.00% -30.88% 0.00% -15.00% -82.76% -2.70% 36.00% 48.39% 47.42% 7.41% 66.67% 24.14%
-0.12 -0.47 1.19 0.91 0.53 0.75 1.45 0.48 0.50 0.75 0.32 0.44 0.39
EPS in Rs -0.24 -0.94 2.38 1.82 1.06 1.50 2.90 0.96 1.00 1.50 0.64 0.88 0.78
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -15%
5 Years: -44%
3 Years: -29%
TTM: -48%
Compounded Profit Growth
10 Years: 14%
5 Years: -21%
3 Years: -4%
TTM: -3%
Stock Price CAGR
10 Years: 3%
5 Years: -8%
3 Years: -2%
1 Year: -35%
Return on Equity
10 Years: 15%
5 Years: 7%
3 Years: 7%
Last Year: 6%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00
Reserves -3.62 -4.09 -2.91 -2.01 -1.49 -0.73 0.70 1.17 1.67 2.41 2.71 3.12
0.00 0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.08 0.11 0.00 0.00
1.03 1.36 1.13 0.92 1.59 1.86 2.11 1.04 1.19 1.23 1.71 1.66
Total Liabilities 2.41 2.27 3.22 3.91 5.17 6.13 7.81 7.21 7.94 8.75 9.42 9.78
1.42 0.73 0.72 2.25 1.99 1.91 1.86 2.07 2.00 1.91 1.81 1.72
CWIP 0.00 0.00 0.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
0.98 1.53 1.69 1.65 3.17 4.21 5.94 5.13 5.93 6.83 7.60 8.05
Total Assets 2.41 2.27 3.22 3.91 5.17 6.13 7.81 7.21 7.94 8.75 9.42 9.78

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0.01 0.75 0.74 0.39 1.03 0.47 2.27 0.38 0.64 0.22 0.27
0.00 -0.74 -0.69 -0.37 -1.06 0.01 -2.61 -0.55 -0.64 -0.23 -0.26
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Net Cash Flow -0.01 0.01 0.05 0.01 -0.03 0.48 -0.34 -0.17 0.00 0.00 0.02
Free Cash Flow -0.01 -0.06 -0.04 0.39 1.03 0.47 1.96 0.35 0.64 0.22 0.26
CFO/OP 7% 343% -198% -61% -251% 68% -284% -46% -57% -25% -11%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 6.67 66.36 5.59 8.62 23.17 3.22 141.51 10.14 3.58 13.04 11.97 19.73
Inventory Days 335.80 136.88 121.67 52.14 2,049.62 272.56 7.24 196.54 127.75 164.25 230.53 405.56
Days Payable 150.87 76.04 76.04 5.79 1,628.46 189.61 51.70 56.15 0.00 18.25 0.00 40.56
Cash Conversion Cycle 191.60 127.20 51.22 54.97 444.33 86.18 97.05 150.52 131.33 159.04 242.49 384.73
Working Capital Days 38.33 22.12 85.31 175.31 457.70 30.06 79.37 -60.83 114.51 91.25 29.92 88.78
ROCE % -10.81% -39.30% 80.00% 31.50% 17.66% 25.48% 45.14% 15.67% 15.02% 11.35% 12.61% 7.33%

Insights

In beta
Mar 2016 Mar 2017 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Export of Goods (FOB Value)
Rs Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Lease Income (Rent on Leasehold Land)
Rs Lakhs
Manufactured Goods Revenue
Rs Lakhs
Traded Goods Revenue
Rs Lakhs
Number of Permanent Employees
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53%
0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19%
40.27% 40.28% 40.26% 40.27% 40.27% 40.28% 40.27% 40.28% 40.28% 40.27% 40.26% 40.26%
No. of Shareholders 6,8226,8447,1466,9006,9367,1867,1807,1737,3507,2447,1727,136

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents